AFP and hepatocellular carcinoma: At present, tumor markers are mainly used in the diagnosis, and evaluation of curative effects, recurrence, and prognosis of malignant tumors.15 Park et al16 retrospectively analyzed the medical records of 156 patients (79 hepatocellular carcinoma 77 liver cirrhosis) and found that AFP was high in patients with hepatocellular carcinoma.